![Michael Landsittel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Landsittel
Direttore/Membro del Consiglio presso
DAMORA THERAPEUTICS, INC.
Profilo
Attualmente, Michael Landsittel ricopre la posizione di direttore finanziario di Blueprint Medicines Corp. Nella sua carriera passata il signor Landsittel ha ricoperto la posizione di direttore finanziario di Infinity Pharmaceuticals, Inc. e di direttore senior delle finanze di Algeta US LLC. Il signor Landsittel ha conseguito una laurea presso l'Università del Michigan e un MBA presso la Tuck School of Business di Dartmouth.
Posizioni attive di Michael Landsittel
| Società | Posizione | Inizio |
|---|---|---|
| DAMORA THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 23/03/2026 |
Precedenti posizioni note di Michael Landsittel
| Società | Posizione | Fine |
|---|---|---|
| BLUEPRINT MEDICINES CORPORATION | Direttore Finanziario/CFO | 01/11/2025 |
Algeta US LLC
 Algeta US LLC Pharmaceuticals: MajorHealth Technology Engages in developing, manufacturing and marketing novel targeted therapies for patients with cancer | Direttore Finanziario/CFO | 01/07/2014 |
| INFINITY PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/10/2012 |
Formazione di Michael Landsittel
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
89
Relazioni di 1° grado
6
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Infinity Pharmaceuticals, Inc.
 Infinity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for the treatment of cancer | Health Technology |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Blueprint Medicines Corp.
 Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
Tuck School of Business at Dartmouth
 Tuck School of Business at Dartmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Algeta US LLC
Algeta US LLC Pharmaceuticals: MajorHealth Technology Engages in developing, manufacturing and marketing novel targeted therapies for patients with cancer | Health Technology |
Galecto, Inc.
 Galecto, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of severe diseases | Health Technology |
